NDC 58048-0005 – Lyme and Co-Infection Nosode

Angelica Archangelica Root 2 [hp_X]/mL; Potassium Chloride 3 [hp_X]/mL; Yucca Filamentosa 3 [hp_X]/mL; Sus Scrofa Cartilage 4 [hp_X]/mL; Phytolacca Americana… · Liquid · Oral

Human Otc Drug

Product NDC58048-0005

Product details

Brand name
Lyme and Co-Infection Nosode
Generic name
Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia prowazekii), Chlamydia Trachomatis, Ledum Palustre
Labeler
Bhp Holdings, Inc.
Dosage form
Liquid
Route
Oral
Marketing category
UNAPPROVED HOMEOPATHIC
Marketed since
March 17, 2020
Marketing end
September 19, 2027
Pharmacologic class
Anti-coagulant; Calculi Dissolution Agent; Calculi Dissolution Agent; Osmotic Laxative; Osmotic Laxative; Potassium Salt

Active ingredients

Uses, dosage, side effects and warnings for Lyme and Co-Infection Nosode →

Package NDC codes (1)

Package NDCDescriptionSince
58048-0005-160 mL in 1 BOTTLE, DROPPER (58048-0005-1)Mar 17, 2020